iStock-952771706

Boca Biolistics Blog

    March is colorectal cancer awareness month. Colorectal cancer is the third most common cancer in the U.S. and is often lethal. There is as yet no magic cure for colorectal cancer, but there are a number of advances being made in both treatments and screening.

    Our modern world runs on data. Sometimes, it might seem like it runs on it too much. In the life sciences, the gathering of large quantities of data, combined with major advances in data analytics, has much promise for improving care and outcomes, but also potential flaws.

    Clinical trials are a vital stage in getting a new treatment or therapy to the market, but they have become more and more expensive in recent years. Costs are higher in some therapeutic areas than others, but can run into millions of dollars for each phase of the trial. In 2012, one estimate was...

    The changing landscape of molecular diagnostic testing provides for the growth of personalized medicine in oncology, pathology, and neurological disorders, so far. Molecular sequencing provides opportunities for more advanced testing of multiple types of genome diagnostics so that laboratories...

    Breakthroughs in cancer research are happening and more are on the horizon. One of the things supporting this is improvements in collection and analysis of biospecimens, allowing researchers to get the data they need quickly and easily. These biospecimens can lead to fascinating discoveries in...

    Boca Biolistics is proud to play a role in infectious disease research. We've been an instrumental partner in the development of Zika diagnostic assays.

    A common fallacy is that there can be a cure for cancer. We talk about it all the time. "That person is brilliant, they'll cure cancer." Every patient and every cancer is different, so there simply cannot be a single cure for cancer, but immunotherapy provides personalized treatments that can...